[Corrigendum] GINS2 is a novel prognostic biomarker and promotes tumor progression in early‑stage cervical cancer

Fei Ouyang,Junling Liu,Meng Xia,Chuyong Lin,Xianqlu Wu,Liping Ye,Libing Song,Jun Li,Jing Wang,Peng Guo,Mian He

DOI: https://doi.org/10.3892/or.2021.8016

2021-01-01

Oncology Reports

Abstract:Subsequently to the publication of the above article, the authors have realized that Figs. 2 and 6 each contained an incorrectly assembled data panel: Essentially, a couple of the data panels had been inadvertently selected twice for these figures. The corrected versions of Figs 2 and 6, including the correct data for the HE DOI: 10.3892/or.2017.5573].